Inimmune

Inimmune is a biotechnology company based in Missoula, Montana, specializing in the research and development of novel immunotherapies and vaccine adjuvants designed to enhance immune system responses against infectious diseases, allergies, and cancer. The company generates revenue through partnerships, licensing agreements, and the advancement of proprietary compounds targeting both human and animal health markets. Founded in 2016 by a team of former GlaxoSmithKline scientists, Inimmune leverages expertise in Toll-like receptor (TLR) agonists and other immune-modulating technologies. Notably, the company has received significant grant funding from agencies like the NIH and has established collaborations with leading pharmaceutical firms. Candidates should be aware of Inimmune’s innovative approach and its rapid growth within the immunotherapy and vaccine development landscape.

Recent Posts by Inimmune

1-2 of 2